Confirm patient eligibility; ensure no active infection at the injection site or systemic infection. Cease anti-inflammatory medications 5-7 days prior if clinically permissible. Patient should fast for 2 hours if required for blood collection, though generally not necessary. Obtain informed consent and verify coagulation profile if indicated.
Patient is monitored for 15-30 minutes post-injection. Apply ice pack to the site for 15 minutes. Avoid heavy physical activity or impact sports for 48-72 hours. Avoid NSAIDs for 1-2 weeks post-procedure. Patient may resume normal non-strenuous daily activities immediately. Follow-up assessment in 4-6 weeks.
Comprehensive Clinical Guide: Platelet-Rich Plasma (PRP) Injection for Knee Osteoarthritis and Soft Tissue Injury
1. Introduction & Overview
Platelet-Rich Plasma (PRP) therapy represents a paradigm shift in regenerative orthopedics. Unlike traditional symptomatic treatments that focus on masking pain—such as corticosteroid injections or non-steroidal anti-inflammatory drugs (NSAIDs)—PRP aims to harness the patient’s intrinsic biological potential to modulate inflammation and stimulate tissue repair.
In the context of the knee, PRP is utilized as an autologous blood-derived concentrate containing a supra-physiological concentration of platelets, growth factors, and cytokines. By concentrating these bioactive components, clinicians can deliver a potent "healing cocktail" directly into the intra-articular space or damaged soft tissues (ligaments/tendons), effectively shifting the joint environment from a catabolic (breakdown) state to an anabolic (building) state.
2. Technical Specifications & Mechanisms of Action
The efficacy of PRP is dictated by its biological composition. The process involves drawing whole blood, which is then centrifuged to separate the components.
The Biological Cascade
PRP functions primarily through the degranulation of alpha-granules within platelets. Upon activation, these granules release a complex array of growth factors:
| Growth Factor | Primary Function in Knee Tissue |
|---|---|
| TGF-β (Transforming Growth Factor-beta) | Promotes chondrocyte proliferation and matrix synthesis. |
| PDGF (Platelet-Derived Growth Factor) | Stimulates angiogenesis and collagen deposition. |
| VEGF (Vascular Endothelial Growth Factor) | Enhances blood vessel formation to improve nutrient delivery. |
| IGF-1 (Insulin-like Growth Factor) | Critical for cartilage maintenance and anabolic signaling. |
| EGF (Epidermal Growth Factor) | Supports epithelial and mesenchymal cell differentiation. |
Classification of PRP
Not all PRP is created equal. The clinical outcome is highly dependent on the preparation protocol:
* Leukocyte-Rich PRP (LR-PRP): Contains high concentrations of white blood cells. Often favored for tendonitis, but can be pro-inflammatory in the intra-articular knee space.
* Leukocyte-Poor PRP (LP-PRP): Primarily used for knee osteoarthritis (OA). By minimizing leukocytes, the injection reduces the risk of post-injection flare-ups and maximizes the chondroprotective effects.
3. Clinical Indications & Patient Selection
PRP is not a "magic bullet" for end-stage bone-on-bone arthritis. Patient selection is the single most important factor for success.
Primary Indications
- Knee Osteoarthritis (Kellgren-Lawrence Grades I-III): Most effective in early to moderate stages where cartilage degradation has not yet resulted in total joint collapse.
- Patellar Tendinopathy: Chronic "Jumper’s Knee" that has failed conservative physical therapy.
- Meniscal Tears: Specifically stable, degenerative tears that are not candidates for surgical excision.
- Post-Surgical Augmentation: Used during ACL reconstruction or high tibial osteotomy to accelerate healing of the graft or bone-tendon interface.
Contraindications
- Absolute: Active systemic infection, localized knee infection, malignancy, or metastatic disease.
- Relative: Platelet dysfunction syndromes, critical thrombocytopenia (platelet count <100,000/μL), active tobacco use (which inhibits healing), and recent use of blood thinners (must be managed with clinical oversight).
4. The Procedure: Step-by-Step Protocol
Phase I: Preparation & Phlebotomy
- Patient Screening: Verification of coagulation status.
- Blood Draw: 20mL to 60mL of whole blood is drawn, typically from the antecubital vein, using a specialized anticoagulant-coated collection system.
- Processing: The blood is placed in a centrifuge. The speed and duration are calibrated to separate the Platelet-Poor Plasma (PPP), the Buffy Coat (rich in platelets and leukocytes), and the Red Blood Cells (RBCs).
Phase II: The Injection
- Sterile Field: The knee is cleaned with chlorhexidine or povidone-iodine.
- Guidance: Ultrasound guidance is the gold standard, ensuring the needle enters the suprapatellar pouch or the specific site of the lesion (e.g., the meniscus).
- Aspiration: If a large effusion is present, the synovial fluid is aspirated to reduce intra-articular pressure before injecting the PRP.
- Delivery: The PRP concentrate (typically 3-6mL) is injected slowly to minimize post-procedural discomfort.
5. Post-Op Recovery & Rehabilitation
Recovery is not passive. To achieve optimal results, a structured rehabilitation program is required.
- Days 1–3 (Inflammatory Phase): Relative rest. Ice application is permitted, but NSAIDs (Ibuprofen, Naproxen) must be avoided for at least 7–14 days, as they may inhibit the inflammatory cascade necessary for the growth factors to initiate healing.
- Days 4–14 (Proliferative Phase): Gentle range-of-motion exercises. Avoiding heavy impact or strenuous loading of the joint.
- Weeks 2–6 (Remodeling Phase): Gradual introduction of resistance training and functional strengthening. Focus on quadriceps and gluteal activation to offload the knee joint.
6. Risks, Side Effects, and Potential Complications
While PRP is autologous and carries a low risk of immune reaction, procedural risks remain:
* Post-Injection Flare: An intense inflammatory reaction lasting 24–48 hours, characterized by increased swelling and warmth. This is common and usually self-limiting.
* Infection: Extremely rare (<0.01% with proper aseptic technique).
* Neurovascular Injury: Rare risk of hitting a superficial nerve or vessel; mitigated by ultrasound guidance.
* Failure to Respond: The most common "complication." Patients must be informed that response rates vary and some individuals may not experience significant symptom relief.
7. FAQ: Frequently Asked Questions
1. Does PRP regrow cartilage?
Current clinical evidence suggests PRP slows the progression of cartilage degradation and improves the quality of the synovial environment. While some MRI studies suggest stabilization of cartilage thickness, it is not currently considered a "cure" for complete cartilage loss.
2. How many injections do I need?
Most clinical protocols call for a series of 1 to 3 injections, spaced 2 to 4 weeks apart, depending on the severity of the condition.
3. Will my insurance cover this?
In many jurisdictions, PRP is still considered "investigational" or "experimental" by private insurance carriers. Patients should verify coverage before proceeding.
4. How long does it take to feel better?
Patients often report improvement between 4 and 8 weeks post-injection. The growth factor cascade requires time to modulate cellular behavior.
5. Can I take Tylenol if I am in pain?
Yes. Acetaminophen is permitted because it does not have the same anti-inflammatory properties as NSAIDs and will not interfere with the PRP healing process.
6. Are there specific age limits?
No. However, biological age and nutritional status can influence the quality of the platelets. Older patients with chronic metabolic conditions may have less robust PRP.
7. Is the procedure painful?
The blood draw is routine. The injection itself can be uncomfortable due to the pressure of the fluid entering the joint, but most patients find it tolerable, especially with local lidocaine infiltration of the skin/subcutaneous tissue.
8. How long does the benefit last?
Clinical studies indicate that the effects of PRP for knee osteoarthritis can last anywhere from 6 to 18 months.
9. Can I work out after the procedure?
You should avoid strenuous activity for 48 hours. After that, you may resume light activity as tolerated, avoiding high-impact exercises for the first 2 weeks.
10. What is the difference between PRP and Stem Cell Therapy?
PRP uses platelets to stimulate your own cells to heal. Stem cell therapy (BMAC or Adipose-derived) uses progenitor cells to potentially differentiate into new tissue. PRP is generally more cost-effective and carries less risk than harvesting stem cells.
8. Alternative Treatments for Knee Pain
When PRP is not the correct clinical choice, the following alternatives are considered:
* Hyaluronic Acid (Viscosupplementation): Acts as a lubricant for the joint.
* Corticosteroid Injections: Excellent for immediate, short-term inflammation control, though repeated use can be detrimental to cartilage.
* Prolotherapy: Injection of hypertonic dextrose to stimulate a localized healing response.
* Physical Therapy: The cornerstone of all knee management, focusing on kinetic chain optimization.
* Surgical Intervention: Arthroscopy, osteotomy, or total knee arthroplasty (TKA) for end-stage mechanical failure.
Conclusion
PRP therapy for the knee is a sophisticated, evidence-based intervention that bridges the gap between conservative management and invasive surgery. By leveraging the body’s own regenerative capacity, it offers a pathway for pain reduction and functional improvement in patients who are not yet ready for, or are not candidates for, surgical joint replacement. Success relies on meticulous preparation, accurate, image-guided delivery, and a patient committed to the post-procedural rehabilitation protocol.